Portal de Periódicos da CAPES

HER2-Low Breast Cancer: Pathological and Clinical Landscape

2020; Lippincott Williams & Wilkins; Volume: 38; Issue: 17 Linguagem: Inglês

10.1200/jco.19.02488

1527-7755

Paolo Tarantino, Erika Hamilton, Sara M. Tolaney, Javier Cortes, Stefania Morganti, Emanuela Ferraro, Antonio Marra, Giulia Viale, Dario Trapani, Fátima Cardoso, Frédérique Penault‐Llorca, Giuseppe Viale, Fabrice André, Giuseppe Curigliano,

Breast Cancer Treatment Studies

Article Tools REVIEW ARTICLES Article Tools OPTIONS & TOOLS Export Citation Track Citation Add To Favorites Rights & Permissions COMPANION ARTICLES No companion articles ARTICLE CITATION DOI: 10.1200/JCO.19.02488 Journal of Clinical Oncology - published online before print April 24, 2020 PMID: 32330069 HER2-Low Breast Cancer: Pathological and Clinical Landscape Paolo Tarantino, MD1,2xPaolo TarantinoSearch for articles by this author; Erika Hamilton, MD3xErika HamiltonSearch for articles by this author; Sara M. Tolaney, MD, MPH4xSara M. TolaneySearch for articles by this author; Javier Cortes, MD, PhD5,6xJavier CortesSearch for articles by this author; Stefania Morganti, MD1,2xStefania MorgantiSearch for articles by this author; Emanuela Ferraro, MD1,2xEmanuela FerraroSearch for articles by this author; Antonio Marra, MD1,2xAntonio MarraSearch for articles by this author; Giulia Viale, MD1,2xGiulia VialeSearch for articles by this author; Dario Trapani, MD1,2xDario TrapaniSearch for articles by this author; Fatima Cardoso, MD7xFatima CardosoSearch for articles by this author; Frédérique Penault-Llorca, MD, PhD8,9xFrédérique Penault-LlorcaSearch for articles by this author; Giuseppe Viale, MD1,2xGiuseppe VialeSearch for articles by this author; Fabrice Andrè, MD, PhD10xFabrice AndrèSearch for articles by this author; and Giuseppe Curigliano, MD, PhD1,2xGiuseppe CuriglianoSearch for articles by this author Show More 1European Institute of Oncology IRCCS, Milan, Italy2University of Milan, Milan, Italy3Sarah Cannon Research Institute/Tennessee Oncology, Nashville, TN4Dana-Farber Cancer Institute, Boston, MA5IOB Institute of Oncology, Quiron Group, Madrid and Barcelona, Spain6Vall d’Hebron Institute of Oncology, Barcelona, Spain7Breast Unit Champalimaud Clinical Center/Champalimaud Foundation, Lisbon, Portugal8Jean Perrin Comprehensive Cancer Center, Department of Pathology and Tumor Biology, Centre Jean Perrin, Clermont-Ferrand, France9UMR INSERM 1240 IMoST, Université Clermont Auvergne, Villejuif, France10Department of Medical Oncology, Gustave Roussy, Villejuif, FranceF.A. and G.C. contributed equally to this work. https://doi.org/10.1200/JCO.19.02488 First Page Full Text PDF Figures and Tables © 2020 by American Society of Clinical Oncology